Cite
HARVARD Citation
Danese, S. et al. (n.d.). OP24 Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study. Journal of Crohn's and colitis. pp. i026-i027. [Online].